Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)

A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach?

(2014) Nichola Cooper   BRITISH JOURNAL OF HAEMATOLOGY

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

(2013) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

(2013) Francesco Rodeghiero et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

(2013) M. Khellaf et al.   HAEMATOLOGICA

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

(2012) W. Ghanima et al.   BLOOD

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

(2012) V. L. Patel et al.   BLOOD

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

(2012) M. N. Saleh et al.   BLOOD

Bleeding severity as an important outcome in childhood immune thrombocytopenia

(2012) Adolfo Flores et al.   PEDIATRIC BLOOD & CANCER

Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia

(2012) Galila M. Mokhtar et al.   PLATELETS

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

(2011) J. B. Bussel et al.   BLOOD

Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP)

(2011) Robert J. Klaassen et al.   PEDIATRIC BLOOD & CANCER

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

(2010) T. B. GERNSHEIMER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia

(2010) Nichola Cooper et al.   Current Rheumatology Reports

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim

(2009) D. J. Kuter et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases

(2009) B. Psaila et al.   BLOOD

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials

(2008) James N. George et al.   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET